GGrantIndex
← Search

Eastern Cooperative Oncology Group Operations Office

$139,560U10FY2013CANIH

Frontier Sci & Technology Rsch Fdn, Inc, Boston MA

Investigators

Linked publications, trials & patents

Trial NCT02201992Trial NCT02194829Trial NCT02115282Trial NCT02085408Trial NCT02048813Trial NCT02031536Trial NCT02003222Trial NCT01989572Trial NCT01950390Trial NCT01898494Trial NCT01863550Trial NCT01856192Trial NCT01824901Trial NCT01824875Trial NCT01824823Trial NCT01708954Trial NCT01708941Trial NCT01642251Trial NCT01575548Trial NCT01381692Trial NCT01274338Trial NCT01251861Trial NCT01169337Trial NCT01164228Trial NCT01145508Trial NCT01142388Trial NCT01134614Trial NCT01105390Trial NCT01078454Trial NCT01078441Trial NCT01004978Trial NCT00986674Trial NCT00976677Trial NCT00955305Trial NCT00899418Trial NCT00887159Trial NCT00843882Trial NCT00634244Trial NCT00602641Trial NCT00588770Trial NCT00551759Trial NCT00522392Trial NCT00433537Trial NCT00433511Trial NCT00378703Trial NCT00357760Trial NCT00337077Trial NCT00326898Trial NCT00324805Trial NCT00321685Trial NCT00313586Trial NCT00310180Trial NCT00305877Trial NCT00303628Trial NCT00274924Trial NCT00262925Trial NCT00258349Trial NCT00253370Trial NCT00227591Trial NCT00217737Trial NCT00217425Trial NCT00131937Trial NCT00119262Trial NCT00112905Trial NCT00110019Trial NCT00108732Trial NCT00104884Trial NCT00103259Trial NCT00103207Trial NCT00103194Trial NCT00101283Trial NCT00098787Trial NCT00098475Trial NCT00096174Trial NCT00093470Trial NCT00090974Trial NCT00089297Trial NCT00088907Trial NCT00088881Trial NCT00087269Trial NCT00087139Trial NCT00085280Trial NCT00083226Trial NCT00080938Trial NCT00079040Trial NCT00077428Trial NCT00077376Trial NCT00077363Trial NCT00077350Trial NCT00075946Trial NCT00075881Trial NCT00071994Trial NCT00071981Trial NCT00070291Trial NCT00068692Trial NCT00068393Trial NCT00064350Trial NCT00063986Trial NCT00060346Trial NCT00057954

Abstract

DESCRIPTION (Provided by applicant): The Eastern Cooperative Oncology Group (ECOG) is a multidisciplinary cancer clinical trials research group dedicated to the treatment, prevention, and cure of adult malignancies. The Operations Office grant application requests funding to support the activities of the group headquarters. Under the direction of the Principal Investigator, Robert L. Comis, MD, the ECOG Operations office is responsible for organizing and coordinating the scientific and administrative activities of the Group; these activities include protocol development, correlative study development, dissemination of necessary information to Group members, organization of Group meetings, maintenance of Group membership and publications, monitoring of compliance with regulatory requirements, adverse event (AE) reporting and review, administration of the audit program, the development and maintenance of standard operating procedures (SOPs), and the management and disbursement of Group funds. Funding requested by the ECOG Operations Office Grant includes support for the Chairs of the ECOG Scientific and Administrative Committees. Additionally funding is requested in this application for member institution accruals to therapeutic and non-therapeutic clinical trials. This application requests funding for the period 05/01/2010 - 04/30/2016. RELEVANCE: The primary goal of the ECOG Operations Office is to provide the support necessary to conduct relevant and rigorous clinical trials, which benefit public health by improving the quality and standard of care for cancer patients.

View original record on NIH RePORTER →